Background: Antenatal iron-folic acid (IFA) supplementation improves maternal anemia and poor pregnancy outcomes.
Introduction
Globally, in 2013 ;6.3 million children died before reaching their fifth birthday (1) . Of these deaths, 2.8 million were neonatal deaths (first 28 d of life), 1.8 million were postneonatal deaths (between 1 and 11 mo of age), and 1.7 million deaths occurred between 12 and 59 mo of age (1) . Under-5 mortality has been reduced by 49% from 1990 to 2012, and neonatal mortality, which contributes to 44% of under-5 deaths, has only been reduced by 39% during the same period of time (1) . In Nepal, under-5 mortality has declined by 72% and neonatal mortality by 57% between 1990 and 2012 (1) . The fourth Millennium Development Goal (MDG) 8 aims to reduce under-5 deaths by two-thirds by 2015, with a global target of 30 under-5 deaths per 1000 live births (1) . Hence, substantial efforts will be required in low-and middle-income countries to achieve the fourth MDG target.
Research has shown that anemia in the first or second trimester of pregnancy is associated with a substantially higher risk of low birth weight (OR: 1.29) and preterm birth (OR: 1.21) (2) . Iron deficiency is the most common cause of anemia during pregnancy and daily use of iron supplements during pregnancy significantly reduces the prevalence of maternal anemia by 50% and risk of low birth weight by 19% (2, 3) . Antenatal use of iron-folic acid (IFA) supplements also has an effect on child survival (4) (5) (6) . The mechanism by which antenatal IFA supplementation reduces child mortality is not yet known. Studies have reported an association between antenatal IFA supplementation and a reduction in low birth weight (2, 4, 7) and preterm delivery (4) . Preterm births contribute to 29% of neonatal deaths (8) and 14% of under-5 deaths globally (9) . It is reported that preterm births lead to a 6.8 times higher risk of neonatal deaths and a 2.5 times higher risk of postneonatal deaths compared with term births (10) . Furthermore, anemia during pregnancy is also associated with a higher risk of birth asphyxia (11, 12) , which leads to neonatal mortality (9) and morbidity beyond the neonatal period (13) . Anemia is also associated with poor body temperature regulation in both animal and human models (14) . Hypothermia in neonates is a major public health problem in high-altitude countries such as Nepal, where 92% of babies have been found hypothermic during the neonatal period (15) . It is plausible that increased iron stores in children may contribute to the reduction of under-5 mortality associated with use of IFA supplements in pregnancy. However, a large-sample cluster randomized controlled trial from Nepal found no effect of daily supplementation of IFA in children 1-36 mo of age on childhood mortality (16) . Thus, it is suggested that infant stores after birth are not critical in reducing childhood mortality, and the risk of preterm birth, birth asphyxia, or poor temperature regulation may be the mechanism responsible for reduced under-5 mortality.
The current WHO guidelines recommend a standard daily oral dose of 30-60 mg of iron and 400 mg of folic acid supplements throughout pregnancy, to begin as early as possible as a part of antenatal care (ANC) programs. In addition, where the prevalence of anemia in pregnancy is >40%, a daily dose of 60 mg of elemental iron is preferred over a lower dose of 30 mg (17). Like most low-and middle-income countries, Nepal has long had a policy of universal distribution of daily IFA supplementation to pregnant women starting at the beginning of the second trimester of pregnancy and continuing through 45 d postpartum (18) . The coverage of antenatal IFA supplementation in Nepal has increased from 23% in 2001 (19) to 80% in 2011 (20) , mainly because of a stronger IFA supplementation program (18) . The aim of the current study was to assess the relative contribution of antenatal IFA supplementation on the risk of mortality in children <5 y of age in Nepal over a 15-y period from 1996 to 2011.
Methods
Data sources. Pooled data from the 2001 (19) , 2006 (21) , and 2011 (20) Nepal Demographic and Health Survey (NDHS) were used in the current study. These household surveys have collected information from a nationally representative sample for a wide range of population, health, and nutrition indicators (22) .
The details of the sampling technique have been described elsewhere (22) . The NDHS was designed to produce estimates at the national, regional, and urban/rural levels (20) . Complete histories of the births of the ever-married women of reproductive age were ascertained, and for the last birth during the 5 y before the survey additional details were recorded about the ANC, delivery, and postnatal care services the women received. The birth history listed all of the womenÕs live births in chronologic order, the date of the birth of each child, the singleton or multiple status of the birth, the sex of the child, the survival status of the child on the day of the interview, and, if deceased, the date of death (20) .
Survival information from 12,891 (12,856 weighted) singleton most recent live-born infants (last live birth of each interviewed mother) within 5 y before each interview was used, consisting of 4700 infants from the 2001 NDHS, 4140 infants from the 2006 NDHS, and 4051 infants from the 2011 NDHS ( Figure 1) . Weighting was applied to compensate for the multistage cluster sampling design. On average, the response rate was >98% (19) (20) (21) . We excluded 5 deaths of children in FIGURE 1 Number of eligible women, total births, and last singleton live births during the last 5 y before the interview in 3 demographic and health surveys in Nepal. their fourth year of life from the 2006 NDHS from the analyses because deaths in this age group occurred only in the 2006 survey and their inclusion resulted in an unexpected and unexplained increased mortality rate in the fourth year of life.
Ethics. Informed verbal consent was obtained from each respondent in each NDHS and these surveys were approved by the Nepal Health Research Council (Kathmandu, Nepal), and ICF Macro Institutional Review Board (Maryland). The current secondary analysis protocol was approved by the Human Research Ethics Committee of The University of Sydney.
Primary outcomes. The primary study outcomes were mortality of children <5 y of age in 5 progressively longer cumulative time periods and in 2 mutually exclusive time periods. The 5 cumulative time periods were comprised of early neonatal mortality, defined as deaths <8 d of age; late neonatal mortality, defined as deaths 8-30 d of age; neonatal mortality, defined as deaths <31 d of age; infant mortality, defined as deaths <12 mo of age; and under-5 mortality defined as deaths <60 mo of age (23) . The mortality outcomes examined in the mutually exclusive time periods were neonatal mortality (<30 d of age) and mortality from 1 to <60 mo of age.
Exposure variables. The main exposure variable examined in the current study was the motherÕs reported use of any IFA supplementation during the most recent pregnancy in the last 5 y before the interview. The questions asked in the NDHS related to the use of IFA supplements were as follows: ''During this pregnancy, were you given or did you buy any IFA tablets?'' and ''During the whole pregnancy, for how many days did you take the tablets?'' A mother was classified as using antenatal IFA supplements (any IFA supplementation) if she reported taking IFA supplements for at least a day during pregnancy. We assessed the potential dose response of IFA supplementation on mortality outcomes by comparing the reported number of IFA supplements used as no IFA used, 1-89, 90-149, or 150-240 supplements throughout pregnancy based on IFA supplementation distribution policy in Nepal with initiation of supplements from the second trimester of pregnancy (20) . The maximum number of supplements that could be used was 240 supplements, assuming once daily. We considered reports of using >240 supplements (n = 26) as implausible and these were excluded from the dose-response analyses. We constructed 2 other variables by combining ANC services and IFA supplementation. The question for the use of ANC services in the NDHS was, ''Did you see anyone for ANC for this pregnancy?'' The combination of use of any ANC services and IFA supplementation was considered to evaluate the effects of any IFA supplementation independent of the use of other ANC services.
The effect of the start time of IFA supplementation on mortality outcomes was also assessed. We considered the time of first ANC examination as a surrogate for the start of IFA supplementation as the major source of IFA supplements in public sector maternal and child health services in Nepal. According to the government policy, female community health volunteers are trained to bring rural pregnant women to static health clinics for their first ANC at the beginning of second trimester, where they are provided with IFA supplements. Moreover, we investigated the effect of the number of supplements when started in different months of pregnancy on mortality outcomes. We also investigated the combined effect of the start time with total number of IFA supplements consumed throughout the pregnancy on mortality outcomes. Moreover, we considered that the maximum number of IFA supplements that could be used were 150, 120, 90, 60, and 30 supplements if a woman started in the fifth, sixth, seventh, eighth, and ninth month of pregnancy, based on the timing of the first ANC visits, respectively. Those cases reporting higher than the maximum number of IFA supplements that could be consumed when started in 5-9 mo of pregnancy were excluded [n = 263 (13.3%)] from analyses for timing of the start and number of IFA supplements consumed.
Potential confounding factors. The Mosley and Chen framework (24) of factors associated with child survival in developing countries was adapted for the analysis. In total, we examined 24 potential confounding factors, which were classified into 3 main groups as follows: 1) communitylevel and socioeconomic status variables, 2) maternal and newborn characteristic variables, and 3) perinatal health care service variables. Ten community-level and socioeconomic status variables were assessed in the analyses, which included the type of residence defined as rural or urban areas, ecologic regions, maternal marital status, maternal religion, maternal level of attained education, maternal occupation, paternal level of attained education, paternal occupation, fuel used for cooking, and pooled household wealth index. Six factors of maternal and newborn characteristics were assessed, which included maternal age at first child birth, childÕs sex, a combination of birth rank and birth interval, the maternal desire for the pregnancy, maternal perception of childÕs birth size, and childÕs breastfeeding status. Four perinatal health care variables, which were number of ANC visits, type of birth attendant, mode of delivery, and place of delivery, were also assessed.
In addition to the aforementioned potential confounding factors, we also considered 4 other important factors in our analyses. The variations in the recall period were adjusted by constructing a variable as the difference in days between the date of the birth of the child and the date of the interview. Likewise, to adjust for secular trends in maternal iron status and development of perinatal health services, a variable with the year of birth of the child was constructed. Both of these variables were retained in all regression models. We also adjusted the analyses for the average coverage of bacille Calmette-Guerin vaccine against tuberculosis in each cluster and the average coverage of measles vaccination in each cluster of the survey.
A household wealth index variable was constructed for household economic status by using the pooled NDHS data and a principal component analysis (25) of household facilities and assets including type of toilet; main material of floor; source of drinking water; availability of electricity; and possession of radio, television, refrigerator, telephone, and bicycle. This household wealth index was used to rank households across the 3 surveys and was divided into quintiles for analysis.
The variables of birth rank and birth interval were combined as a 5-category composite variable that consisted of first birth-rank infants, second and third birth-rank infants with a previous birth interval of >2 y, second and third birth-rank infants with a previous birth interval of #2 y, fourth or more birth-rank infants with a previous birth interval of >2 y, and fourth or more birth-rank infants with a previous birth interval of #2 y.
The question for the maternal perception of birth size in the NDHS was, ''When (NAME) was born, was he/she very large, larger than average, average, smaller than average, or very small?'' In the analyses, perceived birth size was considered in place of birth weight because birth weight was reported in <20% of births. Furthermore, we found a close correlation between motherÕs assessment of child size and birth weight in the current data analysis. The mean (95% CI) birth weight of infants perceived as the smallest birth size, smaller than average birth size, average birth size, larger than average birth size, and the largest birth size was 1.97 (1.82, 2.12), 2.43 (2.35, 2.51), 3.02 (2.97, 3.06), 3.56 (3.49, 3.63), and 3.80 (3.63, 3.97) kg, respectively. However, women who reported birth weight had higher socioeconomic status: 41.8% of those who reported birth weight were living in urban areas, 60.4% had secondary or higher education, and 58.3% belonged to the richest household wealth index quintile.
Statistical analysis. Data analysis was performed using STATA 13.1 (StataCorp) with ''svy'' commands for cluster adjustments. Cox regression was used to examine associations between study factors and primary outcomes, initially with unadjusted estimates for each potential factor. Multivariable analyses were undertaken to assess the independent effects of each factor after controlling for covariates. The adequacy of the proportional hazards assumptions of all variables selected in the model were examined visually by examining the log graphs and by using the goodness-of-fit test. All variables selected in the model satisfied the proportional hazard assumption.
A stagewise hierarchical approach was used (26) . First, all community-level and socioeconomic variables were included with backward elimination to remove statistically nonsignificant factors. Next, maternal and newborn characteristics were added with the community-level and socioeconomic variables associated with mortality outcomes. Afterward, perinatal health service variables were assessed. In the last stage, variables related to IFA supplementation were examined separately with the statistically significant community-level, socioeconomic, maternal, and newborn characteristics and perinatal health service variables. The significance level was set at 0.05 unless the variable had been a priori selected for inclusion. HRs and their 95% CIs were considered to examine the study factors on mortality. Plots of adjusted cumulative mortality for neonatal mortality and mortality in children 1 to <60 mo of age were generated based on adjusted models. Furthermore, x 2 -test for trend was used to compare the differences among the timing of the start categories and the number of supplements used categories.
Population attributable risk (PAR) was calculated to assess total risk of mortality outcomes in the general population that was attributable to women who did not use IFA supplements during pregnancy and women who did not start in first 4 mo of pregnancy and did not use 150-240 supplements. We assumed that the association between IFA supplementation and mortality was causal and that removal of IFA supplementation had no effect on the distribution of other risk factors of mortality. The following formula was used to calculate PAR (27) (28) (29) :
where aHR was the adjusted HR for deaths of under-5 children who were born to women who did not use IFA supplements during pregnancy (this aHR is the inverse of the value reported for women who did take IFA supplements) or for deaths of under-5 children born to women who did not start in the first 4 mo of pregnancy and did not use 150-240 supplements. The distribution and trends of community-level, socioeconomic, maternal, and newborn and perinatal health care service characteristics of singleton live births within 5 y before the interview in 3 NDHSs are shown in Table 1 and Supplemental Table 1 . In all of the 3 NDHSs, ;90% of the mothers were living in rural communities. Overall, 59% of the mothers and 44% of the fathers had no education. A substantial majority of the sampled Nepalese women (82%) reported using biomass energy as a fuel for cooking at home. Fifty-seven percent of the sampled Nepalese women were teenagers (<20 y of age) at the time of child birth. Slightly over one-half of the sampled births were boys and the percentage remained similar in all 3 NDHSs. About two-thirds of the women perceived the birth size of their babies as ''average.'' The practice of ever breastfeeding was universal (;98%). The percentage of women using perinatal health services has increased in Nepal from 2001 to 2011. Overall, 30% of the women reported visiting $4 times for ANC services. Home deliveries were common in Nepal because 76% of the women delivered at home; of those delivered at home only 2.2% were delivered by a health professional. The multivariable Cox proportional hazards regression analyses showed that the risk of deaths in under-5 children was significantly higher in children whose mothers were living in the mountain region compared with children whose mothers lived in the terai region, children whose mothers had no education compared with children whose mothers had some education or who completed secondary education and above, children who were a first birth rank or who were the second or third birth rank with a birth interval of #2 y compared with those who were the second or third birth rank with a birth interval of >2 y, and children who were never breastfed compared with those who were breastfed. The risk of deaths in under-5 children were significantly lower in children whose mothers used natural gas as a fuel for cooking compared with mothers who used biomass energy, children whose mothers wanted to have their pregnancy ''later'' compared with mothers who wanted pregnancy ''then,'' and children whose mothers conducted $4 ANC visits during their pregnancy compared with children whose mothers conducted no ANC visits (Supplemental Table 2 ).
The effect of any IFA supplementation on cumulative child mortality indicators and child mortality over a mutually exclusive time period determined by the multivariate analyses in Nepal 2001-2011 is shown in Table 3 . Any reported use of IFA supplements during pregnancy significantly reduced the risk of child deaths for 4 cumulative mortality indicators and for both mutually exclusive time periods after adjustment for potentially confounding community, socioeconomic, maternal, and neonatal and perinatal health service factors. With any use of IFA supplements, the risk of early neonatal mortality was significantly reduced by 45% (aHR: 0.55; 95% CI: 0.38, 0.79; P = 0.002) and by 42% (aHR: 0.58; 95% CI: 0.39, 0.85; P = 0.005) for neonatal mortality. The protective effect of any IFA supplementation in children 1 to <60 mo of age (beyond the neonatal period) was similar to that in the neonatal period (aHR: 0.58; 95% CI: 0.38, 0.88; P = 0.010). Similarly, the risk of infant and under-5 mortality was significantly reduced by 32% (aHR: 0.68; 95% CI: 0.48, 0.95; P = 0.025) and 48% (aHR: 0.52; 95% CI: 0.38, 0.73; P < 0.001), respectively, with any use of antenatal IFA supplements. Furthermore, apart from early neonatal mortality (nonsignificant reduction in mothers >20 y of age; P = 0.17), the effect of IFA supplementation remained similar in child survival in teenage mothers and in mothers >20 y of age (data not shown).
Plots of adjusted cumulative mortality for neonates and children 1 to <60 mo of age by maternal use of IFA supplements during pregnancy are shown in Supplemental Figure 1 . These plots were based on the findings of the models reported in Table  3 . The cumulative mortality in neonates was substantially lower in children whose mothers reported to have any IFA supplementation during their pregnancy. The difference in the cumulative mortality was evident from day 1 after birth and progressivelyincreased throughout the neonatal period (Supplemental Figure 1A) . Similarly, the cumulative mortality of children 1 to <60 mo of age was lower in children whose mothers reported to have any IFA supplementation during their pregnancy. The difference in the cumulative mortality was observed from the second month of life and progressively continued throughout the postneonatal period (Supplemental Figure 1B) . 1 ANC, antenatal care; NDHS, Nepal Demographic Health Survey. 2 Weighting was applied to compensate for the multistage cluster sampling design. 3 The following questions were asked about education in the NDHS: ''Have you ever attended school?'' and ''What is the highest grade you completed?'' A respondent was categorized as having ''no education'' if she reported the highest grade of education as ''0.'' A respondent was categorized as ''some or completed primary education'' if she reported the highest grade of education attained between 1 and 5. A respondent was categorized as ''some or completed secondary and above'' if she reported the highest grade of education attained as ''6 and more.'' Similar classification was used for paternal education. 4 The following question was asked about occupation in the NDHS: ''What is your occupation, i.e., what kind of work do you mainly do?'' A respondent who reported ''not work'' was categorized as ''not working;'' a respondent who reported ''agriculture work'' was categorized as ''working in agriculture;'' a respondent who reported either ''professional/ technical'' or ''clerical'' and ''skilled'' or ''unskilled work'' was categorized as ''working in nonagriculture.'' Similar classification was used for paternal occupation. 5 Pooled household wealth index was constructed by using principal component analysis. Figure 2 presents a forest plot of the effects of the total number of IFA supplements used, the start time of IFA supplementation, and the start time with the number of IFA supplements consumed on the risk of neonatal mortality. A strong dose-response relation was observed (P < 0.001; x 2 -test for trend) with a significant reduction of neonatal mortality of 42% (aHR: 0.58; 95% CI: 0.34, 0.99; P = 0.047) in infants whose mothers consumed 90-149 supplements, but an even greater reduction of neonatal mortality of 55% (aHR: 0.45; 95% CI: 0.25, 0.80; P = 0.007) in infants whose mothers consumed 150-240 supplements, compared with those who did not use any after adjustment for potentially confounding factors. The adjusted risk of neonatal mortality was significantly reduced by 53% (aHR: 0.47; 95% CI: 0.25, 0.90; P = 0.023) in infants whose mother started the supplements in the first or second month of their pregnancy compared with those who did not use any supplements. When starting in the third or fourth month of pregnancy, there was almost similar reduction in the risk of neonatal mortality (51%) compared with starting at 1-2 mo of pregnancy. However, when starting by $5 mo, a nonsignificant reduction in the risk of neonatal mortality was found (P = 0.32). Infants whose mothers started the supplements in the first 4 mo and consumed 150-240 supplements throughout pregnancy showed a significant reduction in neonatal mortality of 55% (aHR: 0.45; 95% CI: 0.24, 0.85; P = 0.013) compared with those who never used any supplements after adjustment for other potential confounding factors. However, regardless of the total number of supplements consumed, we found a significant reduction in the risk of neonatal mortality when starting within the first 4 mo of pregnancy (Figure 2) . Moreover, the risk of neonatal mortality was reduced by 41% (aHR: 0.59; 95% CI: 0.39, 0.89; P = 0.012) in infants whose mothers used any IFA with or without any other ANC services compared with those who never had any ANC services and used any IFA supplements after adjustment for other potential factors (data not shown). Figure 3 shows a forest plot of the effects of the total number of IFA supplements consumed, the start time of the IFA supplementation, and the start time with the number of IFA supplements consumed on under-5 mortality. Similar to neonatal mortality risk reduction, the risk of under-5 mortality was significantly reduced by 52% (P = 0.002) and 57% (P = 0.003) in children whose mothers consumed 90-149 and $150 supplements, respectively. Although of a lesser extent, there was a significant risk reduction of 41% observed in under-5 mortality in children whose mothers consumed 1-89 supplements (aHR: 0.59; 95% CI: 0.42, 0.83; P = 0.002). Like the reduction in the risk of neonatal mortality, the risk of under-5 mortality was significantly reduced by 65% (aHR: 0.35; 95% CI: 0.20, 0.63; P < 0.001) among those infants whose mothers started the supplements in the first 2 mo of pregnancy, and there was a slightly lower reduction in mortality risk of 53% (aHR: 0.47; 95% CI: 0.31, 0.69; P < 0.001) with mothers starting supplementation in the third or the fourth month of pregnancy. However, even when started at $5 mo, there was a significant 33% (P = 0.032) reduction in the risk of under-5 mortality. The risk of under-5 mortality was reduced by 57% (aHR: 0.43; 95% CI: 0.23, 0.78; P = 0.006) in children whose mothers started the supplements in the first 4 mo of their pregnancy and consumed 150-240 supplements compared with those who never used any supplements. A similar protective effect on the risk of under-5 mortality was also found in infants whose mothers started the supplements in the first 4 mo of pregnancy and took 1-149 supplements compared with those who never used any IFA supplements. Furthermore, the risk of under-5 mortality was reduced by 51% (aHR: 0.49; 95% CI: 0.35, 0.68; P < 0.001) in children whose mothers used any IFA with or without any other ANC services (data not shown). Table 4 presents the estimates of PAR for death of under-5 children associated with IFA supplementation and the number of deaths of under-5 children that could be prevented (per annum and in the next 5 y) with universal and 90% coverage of IFA supplementation and use of 150-240 supplements starting in the first 4 mo. Fifteen percent of the under-5 deaths in Nepalese children were attributed to nonuse of any IFA supplementation during pregnancy (PAR: 0.148; 95% CI: 0.050, 0.279). Based on the estimated PAR,~29,000 (;5800 annual) under-5 deaths could be prevented in Nepal in the next 5 y if all pregnant women used any IFA supplementation during their pregnancy. About 19% of under-5 deaths in Nepal were attributed to lack of starting supplementation in the first 4 mo of pregnancy and consuming 1-149 supplements (PAR: 0.194; 95% CI: 0.093, 0.442). With this PAR,~38,000 (;7600/y) under-5 deaths could be prevented in the next 5 y if all Nepalese pregnant women started IFA in the first 4 mo of their pregnancy and consumed 150-240 supplements throughout their pregnancy.
Discussion
Main findings. We found that the risk of neonatal mortality was significantly reduced by 42% in Nepalese children whose mothers reported taking any IFA supplements during their pregnancy during 1996-2011 after adjustment for other potential confounding factors. The protective effect on the risk of mortality was also seen beyond the neonatal period with a similar magnitude of mortality sparing in children 1 to <60 mo of age with maternal use of IFA supplements. We also observed a significant reduction in the risk of infant and under-5 mortality with maternal use of antenatal IFA supplements. The doseresponse analyses showed a 55% reduction in the risk of neonatal mortality in infants whose mothers consumed 150-240 supplements in their pregnancy. We also found a protective effect of an early start of IFA supplements (first 2 mo) in pregnancy on the risk of neonatal mortality (53%, P = 0.023) and, to a greater extent, on under-5 mortality (65%, P < 0.001).
The current secondary analysis of pooled NDHS (2001-2011) is, to our knowledge, the first study from Nepal to investigate an association between antenatal IFA supplementation and reduced risk of childhood mortality using a nationally representative sample. Our findings provide evidence of the effect of antenatal IFA supplementation on under-5 survival. This evidence contributes to the evidence base and helps inform modifications to IFA supplementation policies and programs in Nepal and in other low-and middle-income countries. Promotion of IFA supplementation early in pregnancy could help facilitate reductions in under-5 deaths in low-and middle-income countries and, in turn, contribute to reaching the child survival MDG.
Comparison with other studies. Our study findings are consistent with other studies from China (4), Nepal (6, 7), and Indonesia (5). Zeng and coworkers (4) conducted a cluster randomized controlled trial in China and found a significant reduction by 53% in the risk of early neonatal deaths (0-7 d) and by 47% in the risk of neonatal deaths (0-28 d) in infants whose mothers took IFA supplements during pregnancy compared with folic acid alone. However, studies have shown an effect of antenatal IFA supplementation on child survival beyond the neonatal period also (5-7). Christian et al. (7) performed a cluster randomized double-blinded trial of 4 different combinations of micronutrient supplements in pregnancy in Nepal and found a significant reduction by 47% in the risk of deaths of infants aged 0-3 mo among preterm births whose mothers took any IFA supplements during pregnancy. A subsequent follow-up study found a significant reduction by 31% in the risk of mortality between birth and 7 y of age in children whose mothers consumed any IFA supplements during their pregnancy (6). Dibley et al. (5) performed a pooled data analysis of 4 Indonesia Demographic Health Surveys (1994, 1997, 2002-2003, and 2007 ) with 55,000 singleton live births and 1525 under-5 deaths and found a significant reduction by 39% and 34% in the risk of neonatal and under-5 mortality, respectively, with antenatal IFA supplementation. They also found a significant reduction by 44% in the risk of under-5 mortality in children whose mothers took $120 supplements during their Multivariable Cox proportional hazard regression analysis was used. Adjusted for community-level and socioeconomic status, maternal and newborn characteristics, and perinatal health services variables for child survival and for duration of recall period, year of birth, and the average coverage of bacille Calmette-Guerin vaccine against tuberculosis in each cluster. 2 Fourteen hundred thirty-three missing values were excluded from the analysis. 3 We excluded 263 cases with implausible values of IFA supplements consumed from the analysis of start time with number of IFA supplements used. aHR, adjusted HR; IFA, iron-folic acid.
pregnancy and a significant reduction by 56% in the risk of under-5 mortality in children whose mothers took $120 supplements starting in the first 3 mo of their pregnancy. The similarities in the results between our current study and the Indonesian study could be because of the relatively high percentage of women who started supplements early in their pregnancy (35% in the first 4 mo in Nepal and 52% in the first 3 mo in Indonesia) and who consumed >90 supplements (29% in Nepal and 19% in Indonesia), in both countries. However, unlike our study, the Indonesian study, because of its larger sample size, also examined the effect of IFA supplementation on other mortality indicators, especially mortality on day 0 (first day of life), which showed the largest mortality sparing effect of IFA supplements (5).
Strengths and limitations. The main strength of this study was our sample, which showed a lot of heterogeneity in the use of supplements, allowing us to examine the effects of different timing and number of IFA supplements consumed while controlling for a range of other confounding factors. In addition, the NDHS used the same core questionnaire to collect data and the surveys were implemented by the same organization with robust quality-control methods (19) (20) (21) . Birth history information collected from representative samples of women of Multivariable Cox proportional hazard regression analysis was used. Adjusted for community-level and socioeconomic status, maternal and newborn characteristics, and perinatal health services variables for child survival and for duration of recall period, year of birth, and the average coverage of measles vaccination in each cluster. 2 Fourteen hundred thirty-three missing values were excluded from the analysis. 3 We excluded 263 cases with implausible values of IFA supplements consumed from the analysis of start time with number of IFA supplements used. aHR, adjusted HR. IFA, iron-folic acid.
IFA supplementation and child survival in Nepal 1881 reproductive age in 3 NDHSs allowed us to identify cohorts of women from their most recent live birth 5 y before the interview. Although the information on exposures and outcomes was collected at the same time, the validity of the study was improved because of an appropriate timing sequence of information with mothers recalling the use of IFA supplements before birth, which was an antecedent exposure before the birth outcomes. Restricting the recall of use of health services including IFA to the most recent birth helped minimize the recall bias. The under-5 mortality rate for the same period of time (1996-2011) reported in the 3 NDHSs (19-21) showed only a slight variation between surveys, which suggested a good quality of data collection for births and deaths. Under-reporting of births and deaths is generally more frequent the farther back in time from the interview an event occurred; therefore, to increase the validity of the results and minimize the recall bias, we restricted the data analysis to reports of the most recent birth of each mother with use of services during pregnancy in the last 5 y before the interview date (23, 31, 32) . Furthermore, as suggested by others (33), we also adjusted our analysis for the number of ANC visits. We excluded 5 unusual deaths in the fourth year of life, which were only reported in the NDHS 2006, although including those deaths in the analyses did not alter our main findings.
The key limitation was that the information on child mortality and use of IFA supplements could not be validated because it was based on maternal recall. However, child mortality is a core measure in Demographic Health Surveys and the survey methods used have been carefully examined over many years (34) . In addition, because birth histories and child survival information were only collected from surviving mothers, there is a chance of an underestimate of infant and child mortality (23) . The use of IFA supplements during pregnancy was based on maternal recall and any improvement in iron status could not be assessed. Maternal recall of the number of IFA supplements taken during pregnancy might not have been accurate and may have led to a misclassification of the women on the basis of categories of the number of supplements used. It was not possible to examine the dose of iron in IFA supplements because in the NDHS it was not asked to respondents which preparation of iron they used during pregnancy. In addition, a heaping effect with the numbers of supplements used was also observed in our sample. Anthropometric status of children, although a potential predictor of child mortality, could not be examined in the analyses because anthropometric measurements were not taken for all children. The maternal caste, an important confounder, was not used in the current analysis because responses were not uniformly coded in all 3 NDHSs and it was difficult to group them together. There is a possibility that women have misestimated the month of gestation for their first ANC visit and under-or overestimated the number of IFA supplements used throughout pregnancy. The extent of such misclassification cannot be assessed. Furthermore, this nondifferential misclassification would be expected to reduce dose-response patterns for the number of IFA supplements used or patterns related to the timing of supplementation. Hence, the reported patterns may be less than the true effects.
Effect of IFA supplementation on child survival and recommendations. We found~29,000 under-5 deaths could be prevented in the next 5 y if all pregnant women used any IFA supplements in Nepal. Similarly, if all of the pregnant women consumed 150-240 supplements starting in the first 4 mo of their pregnancy, nearly 38,000 under-5 deaths could be prevented in the next 5 y. In Nepal, the supplements are distributed through health facilities, outreach clinics, and, later, through female community health volunteers (18) . However, unlike many other low-and middle-income countries, Nepal has strengthened its IFA supplementation program at the district level during the last decade (18) , which has resulted in an increased coverage of IFA supplementation from 23% in 2001 to 79% in 2011. Furthermore, the percentage of women who consumed 150-240 supplements starting in the first 4 mo of pregnancy has progressively increased from 2% in 2001 to 41% in 2011. However, like other low-and middle-income countries (35, 36) , the coverage of IFA supplementation in Nepal varied widely across regions; e.g., 84% of pregnant women used IFA in the terai region compared with 73% in the mountain region; and for socioeconomic status groups, 95% of pregnant women used IFA in the highest household wealth quintile compared with 62% in the lowest household wealth quintile (20) . Similar trends have also been seen with the number of supplements consumed (20) . Hence, there is a need to further strengthen the existing IFA supplementation program in Nepal to overcome the regional and socioeconomic status variations. At the same time, based on our study findings, there is a need to test intervention packages through cluster randomized controlled trials in the resource-poor communities of Nepal and other low-and middle-income countries to evaluate the effect of earlier initiation and use of greater number of antenatal IFA supplements on child survival. reviewed the analyses and provided necessary feedback and reviewed and revised the manuscript critically. All authors read and approved the final manuscript.
